Mindaugas J.
- Country
- Lithuania
- Department
- None
Research Overview
- Evaluation of Teverelix DP, a GnRH Antagonist, in Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety for Advanced Prostate Cancer Patients
- Phase 3 Randomized Open-label Study of Opevesostat Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- (20321) An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer sponsored studies
Data & Insights
Has run more than one trial at 18 of 129 partner sites.
Specializations
Urology and Genitourinary Oncology
The clinical research profile includes urologic malignancies and related cancers, with involvement in studies of prostate cancer, urothelial cancer, and non-muscle invasive bladder cancer. This area also extends to renal cell cancer and other advanced solid tumors managed within the Urology Clinic.
- Advanced prostate cancer
- Metastatic castration-resistant prostate cancer
- Bladder cancer
- Urothelial cancer
Research activity in this domain reflects a focus on therapeutic options for advanced disease and treatment-resistant genitourinary cancers.
Inflammatory Bowel Disease and Gastroenterology
Another major area of interest is inflammatory bowel disease, particularly Crohn’s disease and ulcerative colitis. The investigator is also involved in studies addressing gastrointestinal inflammation and long-term disease control in chronic intestinal disorders.
- Crohn’s disease
- Ulcerative colitis
- Moderately to severely active Crohn’s disease
- Moderately to severely active ulcerative colitis
This research landscape includes therapies aimed at controlling intestinal inflammation, maintaining remission, and improving symptom burden in chronic relapsing disease.
Rheumatology and Autoimmune Disease
The investigator is active in rheumatologic and immune-mediated conditions, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and systemic sclerosis. Additional interest is evident in juvenile idiopathic arthritis and other chronic inflammatory disorders.
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Psoriatic arthritis
- Juvenile idiopathic arthritis
Therapeutic work in this field centers on immune modulation for persistent inflammatory disease and preservation of function in long-term autoimmune conditions.
Neurology, Cardiovascular Medicine, and Thrombosis
Clinical trial involvement also spans neurologic and cardiovascular disease, with studies in multiple sclerosis, acute ischemic stroke, atrial fibrillation, heart failure, and atherosclerotic cardiovascular disease. The portfolio includes attention to thromboembolic disease and stroke prevention.
- Multiple sclerosis
- Stroke prevention
- Atrial fibrillation
- Heart failure
This area reflects participation in therapies targeting vascular risk reduction, neuroinflammation, and prevention of clot-related complications.
Metabolic, Renal, and Respiratory Disease
The research landscape further includes metabolic disorders, kidney disease, and airway disease. Areas of activity include type 2 diabetes, chronic kidney disease, immunoglobulin A nephropathy, proteinuria, asthma, and chronic obstructive pulmonary disease.
- Type 2 diabetes
- Chronic kidney disease
- Immunoglobulin A nephropathy
- Asthma
Therapeutic interests in this section include renal protection, cardiometabolic risk management, and control of chronic inflammatory airway disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.